Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: Basic principles and clinical applications

Journal of Magnetic Resonance Imaging

Volumn 6, Issue 2, 1996, Pages 311-321

  Verstraele, Koenraad L ^a   Van Der Woude, Henk Jan ^b   Hogendoorn, Pancras C W ^b   De Deene, Yves ^a   Kunnen, Marc ^a   Bloem, Johannes L ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bones, MR; Dynamic imaging; Gadolinium; Image processing; Magnetic resonance (MR), contrast enhancement; Soft tissues, MR

Indexed keywords

CONTRAST MEDIUM;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; BONE TUMOR; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMAGE PROCESSING; MALE; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MUSCLE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; TUMOR RECURRENCE;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL;

EID: 0030090243     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880060210     Document Type: Article

References (68)

1. Brasch RC. New directions in the development of MR imaging contrast media. Radiology 1992; 183:1-11.
2. Wolf GL. Contrast agents in spine and body MRI: introduction. In: Hasso AN, Stark DD, eds. American Roentgen Ray Society - Categorical Course Syllabus: spine and body magnetic resonance imaging - 1991. Reston, VA: American Roentgen Ray Society, 1991; 111-115.
3. Verstraete KL, De Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging - parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192:835-843.
4. 125I labeled meglumine diatrizoate; early extravascular distribution. Acta Radiol Diagn 1977; 18:293-304.
5. Kormano M, Dean PB. Extravascular contrast material: the major component of contrast enhancement. Radiology 1976; 121:379-382.
6. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med 1993; 30:337-346.
7. Tong CY, Prato FS, Wisenberg G, et al. Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentetate dimeglumine. Magn Reson Med 1993; 30:332-336.
8. Verstraete KL, Achten E, Dierick A, et al. Dynamic contrast enhanced MRI of musculoskeletal neoplasms: different types and slopes of time-intensity curves (abstract). In: Proceedings of the Society of Magnetic Resonance in Medicine 1992. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1992; 2:2609.
9. Ross J, Delamarter R, Hueftle M, et al. Gadolinium-DTPA-enhanced MR imaging of the postoperative lumbar spine: time course and mechanism of enhancement. AJNR 1989; 10:37-46.
10. Verstraete KL, Dierick A, De Deene Y, et al. First-pass images of musculoskeletal lesions: a new and useful diagnostic application of dynamic contrast-enhanced MR imaging. Magn Reson Imaging 1994; 12:687-702.
11. König H, Sieper J, Wolf K. Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. Radiology 1990; 176:473-477.
12. König H, Sieper J, Wolf K. Dynamic MRI for the differentiation of inflammatory joint lesions. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1990; 153:1-5.
13. Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced MR mapping. Invest Radiol 1992; 27:367-373.
14. De Baere T, Vanel D, Shapeero L, Charpentier A, Terrier P, di Paola M. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992; 185:587-592.
15. Erlemann R, Reiser M, Peters P, et al. Musculoskeletal neoplasms: static and dynamic Gd-DTPA enhanced MR imaging. Radiology 1989; 171:767-773.
16. Erlemann R, Sciuk J, Bosse A, et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy Radiology 1990; 175:791-796.
17. Vanel D, Shapeero L, De Baere T, et al. MR imaging in the follow-up of malignant and aggressive soft tissue tumors: results of 511 examinations. Radiology 1994; 190:263-268.
18. Vanel D, Tardivon A, Shapeero L, Western A, De Baere T, Guinebretière JM. Dynamic contrast-enhanced subtraction MR imaging in follow-up of aggressive soft-tissue tumors: a prospective study of 74 patients (abstract). Radiology 1993; 189(suppl):205.
19. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992; 184:243-248.
20. Charpentier E, Bonnerot V, Frouin F, Kalifa C, Vanel D, Di Paola R. Factor analysis processing of dynamic MR imaging: new method to assess osteosarcoma preoperative chemotherapy response (abstract). Radiology 1990; 177(suppl):221.
21. Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Di Paola R. Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 1992; 27:847-855.
22. Mirowitz SA, Totty WG, Lee JKT. Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI. J Comput Assist Tomogr 1992; 16(1):120-125.
23. Mirowitz SA, Totty WG, Lee JKT. Evaluation of musculoskeletal masses with dynamic Gd-DTPA enhanced rapid-acquisition spin-echo imaging (abstract). Radiology 1990; 177(suppl):221.
24. Hanna SL, Fletcher BD, Fairclough DL, Le A. Use of dynamic Gd-DTPA enhanced MRI in musculoskeletal malignancies (paper 101). In: Proceedings of the Society of Magnetic Resonance Imaging 1990; 9.
25. Cova M, Kang Y, Tsukamoto H, et al. Bone marrow perfusion evaluated with gadolinium-enhanced dynamic fast MR imaging in a dog model. Radiology 1991; 179:535-539.
26. Tsukamoto H, Kang Y, Jones L, et al. Evaluation of marrow perfusion in the femoral head by dynamic MRI. Effect of venous occlusion in a dog model. Invest Radiol 1992; 27:275-281.
27. Bollow M, Braun J, Hamm B, et al. Early sacroiliitis in patients with spondylarthropathy: evaluation with dynamic gadolinium-enhanced MR imaging. Radiology 1995; 194:529-536.
28. Reiser M, Bongartz G, Erlemann R, Schneider T, Sittek P, Peters P. Gadolinium-DTPA in rheumatoid arthritis and related diseases: first results with dynamic magnetic resonance imaging. Skeletal Radiol 1989; 18:591-597.
29. Lang P, Stevens M, Vahlensieck M, et al. Rheumatoid arthritis of the hand and wrist: evaluation of soft-tissue inflammation and quantification of inflammatory activity using unenhanced and dynamic Gd-DTPA enhanced MR imaging (Abstract). In: Proceedings of the Society of Magnetic Resonance in Medicine 1990. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1990; 66.
30. Sugimoto H, Miyaji N, Ohsawa T. Carpal tunnel syndrome: evaluation of median nerve circulation with dynamic contrast-enhanced MR imaging. Radiology 1994; 190:459-466.
31. Verstraete KL, Dierick A, De Deene Y, et al. First-pass images of musculoskeletal lesions: a new and useful diagnostic application of dynamic contrast-enhanced MRI (abstract). In: Proceedings of the Society of Magnetic Resonance in Medicine 1993. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1993; 2:869.
32. Verstraete KL, Vanzieleghem B, De Deene Y, et al. Static, dynamic and first-pass imaging of musculoskeletal lesions by use of gadodiamide injection. Acta Radiol 1995; 36:27-36.
33. Verstraete K. Dynamic contrast-enhanced MRI of tumor and tumor-like lesions of the musculoskeletal system (academic thesis). Gent, Belgium: University of Gent, 1994; 63-185.
34. Chien D, Edelman RR. Ultrafast imaging using gradient echos. Magn Reson Q 1991; 7:31-56.
35. Haase A, Matthaei D, Bartkowski R, Dühmke E, Leibfritz D. Inversion recovery snapshot FLASH MR imaging. J Comput Assist Tomogr 1989; 13:1036-1040.
36. Haase A. Snapshot FLASH MRI: applications to T1, T2 and chemical shift imaging. Magn Reson Med 1990; 13:77-89.
37. Van der Woude H, Verstraete K, Taminiau A, Hogendoorn P, Vanzieleghem B, Bloem J. Double slice dynamic contrast-enhanced subtraction MR images in 60 patients with musculoskeletal tumors or tumor-like lesions (abstract). Eur J Radiol 1995; 5(suppl):181.
38. Van der Woude HJ, Bloem JL, Verstraete KL, et al. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR 1995; 165:593-598.
39. Hendrick RE, Raff U. Image contrast and noise. In: Stark DD, Bradley WG, eds. Magnetic resonance imaging. 2nd ed., vol. 1. St. Louis: Mosby Year Book, 1992; 127.
40. Holsinger AE, Riederer SJ. The importance of phase-encoding order in ultra-short TR snapshot MR imaging. Magn Reson Med 1990; 16:481-488.
41. Shapeero LG, Henry-Amar M, Vanel D. Critical review : response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Invest Radiol 1992; 27:989-991.
42. Kashanian FK, Goldstein HA, Blumetti RF, Holyoak WL, Hugo FP, Dolker M. Rapid bolus injection of gadopentetate dimeglumine: absence of side effects in normal volunteers. AJNR 1990; 11:853-856.
43. Chambers TP, Baron RL, Lush RM, Dodd GD, Miller WJ, Confer SR. Hepatic CT enhancement: a method to demonstrate reproducibility. Radiology 1993; 188:627-631.
44. Chambers TP, Baron RL, Lush RM. Hepatic CT enhancement. Part 1. Alterations in the volume of contrast material within the same patients. Radiology 1994; 193:513-517.
45. Chambers TP, Baron RL, Lush RM, Dodd GD, Miller WJ, Confer SR. Hepatic CT enhancement. Part 2. Alterations in contrast material volume and rate of injection within the same patients. Radiology 1994; 193:518-522.
46. Van der Woude HJ, Bloem JL, Schipper J, et al. Changes of tumor perfusion in bone sarcomas induced by chemotherapy: color Doppler flow imaging compared with contrast-enhanced MR imaging and three phase bone scintigraphy. Radiology 1994; 191:421-431.
47. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49:6449-6465.
48. Reddick W, Langston J, Meyer W, et al. Discrete signal processing of dynamic contrast-enhanced MR imaging: statistical validation and preliminary clinical application. J Magn Reson Imaging 1994; 4:397-404.
49. Erlemann R. Dynamic, gadolinium-enhanced MR imaging to monitor tumor response to chemotherapy (letter). Radiology 1993; 186:904-905.
50. Lawrence JA, Babyn P, Chan HSL, Thorner PS, Pron GE, Krajbich IJ. Extremity osteosarcoma in childhood: prognostic value of radiologic imaging. Radiology 1993; 189:43-47.
51. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49:1221-1230.
52. Meyers PA, Heller G, Healey J, et al. Chemotherapy for non-metastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992; 10(1):5-15.
53. Oberlin O, Patte C, Demeocq F, et al. The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma. Eur J Cancer Clin Oncol 1985; 21:463-467.
54. Hudson M, Jaffe MR, Jaffe N, et al. Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience. J Clin Oncol 1990; 8:1988-1997.
55. Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis and therapeutic response in osteogenic sarcoma: the Memorial Hospital experience. Cancer 1992; 69:698-708.
56. Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: result of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor reponse. J Clin Oncol 1988; 6:329-337.
57. Raymond AK, Chawla SP, Carrasco CH, et al. Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol 1987; 4:212-236.
58. Fletcher B, Hanna S. Musculoskeletal neoplasms: dynamic Gd-DTPA-enhanced MR imaging (letter). Radiology 1989; 177: 287-288.
59. Erlemann R, Sciuck J, Wuisman P, et al. Dynamic MR tomography in diagnosis of inflammatory and tumorous space occupying growths of the musculoskeletal system. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1992; 156(4):353-359.
60. Knop J, Delling G, Heise U, Winkler K. Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma: correlation of 99mTC-methylene diphosphonate parametric imaging with surgical histopathology. Skeletal Radiol 1990; 19:165-172.
61. Carrasco C, Chamsangavej C, Raymond A, et al. Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology 1989; 170:839-842.
62. Kumpman W, Lechner G, Wittich GR, et al. The angiographic response of osteosarcoma following preoperative chemotherapy. Skeletal Radiol 1986; 15:96-102.
63. Chuang VP, Benjamin R, Jaffe N, et al. Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. AJR 1982; 139:1065-1069.
64. Vanel D, Lacombe MJ, Couanet D, Kalifa C, Spielmann M, Genin J. Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology 1987; 164:243-245.
65. Reuther G, Mutschler W. Detection of local recurrent disease in musculoskeletal tumors: magnetic resonance imaging versus computed tomography. Skeletal Radiol 1990; 19:85-90.
66. Biondetti PR, Ehman RL. Soft tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MR imaging. Radiology 1992; 183:845-848.
67. Maas R. Radiologische diagnostik der rezidive von weichteilsarkomen. Radiologe 1992; 32:597-605.
68. Bloem JL, Reiser MF, Vanel D. Magnetic resonance contrast agents in the evaluation of the musculoskeletal system. Magn Res Q 1990; 6(2):136-163.